Nayara Sato is a Senior Patent Analyst at Hypera since November 2022, specializing in the preparation of Freedom to Operate reports and conducting impact analysis of patents on pharmaceutical, biologic, and medical device portfolios. Previous experience includes roles as a Scientific Initiation Researcher at the University of São Paulo, R&D Intern at Eurofarma, and R&D Analyst at Brainfarma, where responsibilities ranged from evaluating Drug Master Files for regulatory compliance to supporting innovation projects. Nayara holds a Bachelor's Degree in Chemistry with Emphasis in Biotechnology from the University of São Paulo, a Postgraduate Diploma in Validation in Instrumental Analysis from Faculdades Oswaldo Cruz, and is currently pursuing a Postgraduate Degree in Pharmaceutical Development and Innovation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices